SFCM
LPCN icon

Seven Fleet Capital Management’s Lipocine LPCN Stock Holding History

Seven Fleet Capital Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Sell
78,842
-46,100
-37% -$111K 0.03% 90
2026
Q1 		$998K Buy
+124,942
New +$1.09M 0.31% 58

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Seven Fleet Capital Management's LPCN Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Lipocine (LPCN) stake by 37% in Q2 2026, selling an estimated $111K and leaving 78,842 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #90.

Seven Fleet Capital Management first reported a position in LPCN in Q1 2026 and has held it in 2 quarters since. The position peaked at $998K in Q1 2026. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Seven Fleet Capital Management held 78,842 shares of Lipocine worth $202K as of Q2 2026.
  • Seven Fleet Capital Management sold 46,100 Lipocine shares in Q2 2026, an estimated $111K.
  • Lipocine made up 0.03% of Seven Fleet Capital Management's portfolio in Q2 2026, its #90 holding.
  • Seven Fleet Capital Management first reported a position in Lipocine in Q1 2026 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Lipocine position peaked at $998K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.